Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
02/14/2013 | WO2013023108A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (heteroarylene spacer moiety) |
02/14/2013 | WO2013023107A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (electron withdrawing groups) |
02/14/2013 | WO2013023106A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (acyl moieties) |
02/14/2013 | WO2013021363A1 Quinazoline-2,4-dione derivatives |
02/14/2013 | WO2013021315A1 Process for the preparation of benzohetero [ 1, 3 ] - diazole compounds disubstituted with heteoaryl groups |
02/14/2013 | WO2013021276A1 Trpv1 antagonists including dihydroxy substituent and uses thereof |
02/14/2013 | WO2013020993A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease |
02/14/2013 | WO2013020371A1 Pim kinase inhibitor, preparation method and use thereof in drug preparation |
02/14/2013 | WO2013020370A1 Pim kinase inhibitor and preparation method and use in medicinal manufacture thereof |
02/14/2013 | WO2013020369A1 Pim kinase inhibitor, preparation method therefor, and pharmaceutical application thereof |
02/14/2013 | US20130040999 New compounds for alleviation, prevention or treatment of osteoporosis, the preparation thereof and pharmaceutical composition comprising the same |
02/14/2013 | US20130040992 Substituted 2, 6-Diamino-3, 5-Dicyano-4-Aryl-Pyridines And Their Use As Adenosine-Receptor-Selective Ligands |
02/14/2013 | US20130040951 Prophylactic or therapeutic agent for cancer |
02/14/2013 | US20130040941 Benzodiazepine compound and pharmaceutical composition |
02/14/2013 | US20130040936 1,4-oxazepines as bace1 and/or bace2 inhibitors |
02/14/2013 | US20130040931 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use |
02/14/2013 | US20130040930 Novel amide derivative and use thereof as medicine |
02/14/2013 | US20130039944 Anti-Viral Compounds |
02/14/2013 | US20130039870 Cosmetic Or Dermatological Preparations With A Content Of One Or More Thiazole Derivates |
02/14/2013 | CA2844855A1 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
02/14/2013 | CA2844852A1 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
02/14/2013 | CA2844440A1 Process for the preparation of benzohetero[1,3]diazole compounds disubstituted with heteroaryl groups |
02/14/2013 | CA2842885A1 Quinazoline-2,4-dione derivatives |
02/14/2013 | CA2842123A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease |
02/13/2013 | EP2556072A1 2-phenyl benzothiazole linked imidazole compounds as potential anticancer agents and process for the preparation thereof |
02/13/2013 | EP2556066A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
02/13/2013 | EP2556056A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto |
02/13/2013 | CN102933577A Fungicidal oximes and hydrazones |
02/13/2013 | CN102933575A Yclohexyl-azetidinyl antagonists of ccr2 |
02/13/2013 | CN102933572A Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
02/13/2013 | CN102933548A Carboxamide compounds and their use as calpain inhibitors |
02/13/2013 | CN102933214A 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
02/13/2013 | CN102924446A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
02/13/2013 | CN102924445A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
02/13/2013 | CN102924444A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
02/13/2013 | CN102924443A 5-hydroxy indole derivative contain heterocyclic ring and applications thereof |
02/13/2013 | CN102924442A Chroman compound containing thiazole ring and analogue and medical applications thereof |
02/13/2013 | CN102924441A N-(4-(4-(3-fluorophenyl)piperazin-1-yl)pyrimidin-2-yl)-amide or salts thereof, preparation method and applications |
02/13/2013 | CN102920695A Benzofuran endothelin receptor antagonist and use |
02/13/2013 | CN101868457B (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating |
02/13/2013 | CN101490035B Amino-piperidine derivatives as CETP inhibitors |
02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
02/12/2013 | US8372971 Heterocyclic compounds and methods of use |
02/12/2013 | CA2596527C Igf-1r inhibitors |
02/12/2013 | CA2480638C Substituted benzazoles and use thereof as raf kinase inhibitors |
02/07/2013 | WO2013018929A1 Nitrogen-containing heterocyclic compound |
02/07/2013 | WO2013018735A1 Amidine compound or salt thereof |
02/07/2013 | WO2013018695A1 Heterocyclic compound |
02/07/2013 | WO2013018362A1 2-acylaminothiazole compound crystals |
02/07/2013 | WO2013018095A1 Compounds and compositions for use in augmentation of glucose uptake and insulin secretion |
02/07/2013 | WO2013017657A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
02/07/2013 | WO2012172438A9 Compositions and methods for modulating a kinase |
02/07/2013 | WO2012073041A3 Inhibitors of apurinic/apyrimidinic endonuclease 1 (ape1) and their use |
02/07/2013 | US20130035346 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
02/07/2013 | US20130035342 Compound Suitable for the Treatment of Synucleopathies |
02/07/2013 | US20130035332 Substituted 1,3-Benzothiazol-2(3H)-Ones and [1,3]Thiazolo[5,4-B]Pyridin-2(IH)-Ones as Positive Allosteric Modulators of MGLUR2 |
02/07/2013 | US20130035331 Thiazole and oxazole kinase inhibitors |
02/07/2013 | US20130035329 Therapeutically active compositions and their methods of use |
02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
02/07/2013 | US20130034504 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
02/07/2013 | CA2843805A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
02/07/2013 | CA2843383A1 Amidine compound or salt thereof |
02/06/2013 | EP2552909A1 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists |
02/06/2013 | CN102918031A Radiolabeled compounds and methods thereof |
02/06/2013 | CN102918027A Modulators of the gpr119 receptor and the treatment of disorders related thereto |
02/06/2013 | CN102911170A Method for preparing imide compound hydrochloride |
02/06/2013 | CN102911169A Method for preparing lurasidone |
02/06/2013 | CN102911161A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
02/06/2013 | CN101778834B Novel herbicides |
02/06/2013 | CN101675046B Therapeutic agents |
02/06/2013 | CN101243096B 抗病毒化合物 Antiviral compounds |
02/05/2013 | US8367676 2-carboxamide-7-piperazinyl-benzofuran derivatives 774 |
02/05/2013 | US8367673 Substituted diketopiperazines as oxytocin antagonists |
02/05/2013 | US8367653 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
02/05/2013 | CA2591033C Heterocyclic aspartyl protease inhibitors |
01/31/2013 | WO2013014665A1 Intermediate compounds and process for the preparation of lurasidone and salts thereof |
01/31/2013 | WO2013014445A1 Derivatives of phenyl (thio) urea deoxythymidine and use thereof as antimalarials |
01/31/2013 | WO2013014205A1 Substituted 3 - (thiazole - 4 - carbonyl) - or 3 - (thiazole - 2 - carbonyl) aminopropionic acid derivatives and their use as pharmaceuticals |
01/31/2013 | WO2013014170A1 Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit) |
01/31/2013 | WO2013014165A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
01/31/2013 | WO2013014060A1 Substituted quinolines and their use as medicaments |
01/31/2013 | WO2013014039A1 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors |
01/31/2013 | WO2013013614A1 4-(3-heteroarylarylamino)quinazoline and 1-(3-heteroarylarylamino)isoquinoline as hedgehog pathway inhibitor and use thereof |
01/31/2013 | US20130030180 Methods of Facilitating Neural Cell Survival Using GDNF Family Ligand (GFL) Mimetics or RET Signaling Pathway Activators |
01/31/2013 | US20130030177 Synthesis process of dasatinib and intermediate thereof |
01/31/2013 | US20130030022 Compounds Which Selectively Modulate The CB2 Receptor |
01/31/2013 | US20130030002 Fungicidal oximes and hydrazones |
01/31/2013 | US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
01/31/2013 | US20130029988 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
01/31/2013 | US20130029978 Novel aryl urea derivative |
01/31/2013 | US20130029971 Cxcr3 receptor antagonists |
01/31/2013 | US20130029966 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
01/31/2013 | US20130029949 Substituted Quinolines and Their Use As Medicaments |
01/31/2013 | US20130029938 Chemical Compounds |
01/31/2013 | US20130029901 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
01/31/2013 | US20130029845 Isoxazolines for controlling invertebrate pests |
01/31/2013 | US20130028966 Broad Spectrum Antiviral and Antiparasitic Agents |
01/31/2013 | CA2843022A1 Substituted quinolines and their use as medicaments |